• Cefiderocol Outperforms β-Lactamase Inhibitors in Resistant

  2026-05-17

  This large European study demonstrates that cefiderocol maintains superior in vitro activity against Enterobacterales, including isolates resistant to both meropenem and β-lactam/β-lactamase inhibitor combinations. The findings inform susceptibility testing strategies and highlight the need for robust PK/PD modeling in multidrug-resistant Gram-negative infections.

• High-Throughput BBB Permeability Modeling with Lysosomal Cor

  2026-05-16

  This study introduces a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating a correction for lysosomal drug trapping. The model accurately predicts brain distribution for a diverse set of CNS compounds, offering a validated tool for early-stage drug screening and reducing reliance on animal studies.

• ZCL278 (SKU A8300): Selective Cdc42 Inhibition in Cell Assay

  2026-05-15

  This article guides biomedical researchers through real-world laboratory scenarios where ZCL278 (SKU A8300) offers robust, reproducible solutions for cell viability, proliferation, and motility assays. Drawing on peer-reviewed data and best practices, it details how ZCL278’s selective Cdc42 inhibition enhances workflow reliability and data interpretation.

• Enhanced Activity of Temafloxacin Against Gram-Positive Cocc

  2026-05-15

  This study systematically evaluated the in vitro efficacy of temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, against Gram-positive bacteria isolated from clinical blood cultures. The findings demonstrate temafloxacin's superior potency compared to other quinolones, particularly against Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae, with consistent activity across varying assay conditions. These insights inform antibacterial agent selection for research on resistant Gram-positive pathogens.

• Cefazedone (Refosporen): Optimizing In Vitro and Clinical Wo

  2026-05-14

  Cefazedone (Refosporen) empowers research and clinical teams with robust, β-lactamase-resistant coverage for both Gram-positive and Gram-negative infections. This guide translates reference-backed PK/PD science into actionable protocols, troubleshooting strategies, and performance benchmarks for reliable antibacterial testing and translational applications.

• VX-765: Deep Dive Into Selective Caspase-1 Inhibition Mechan

  2026-05-14

  Explore VX-765, a potent caspase-1 inhibitor, in unprecedented scientific depth. This article uncovers new mechanistic insights and practical assay guidance for researchers studying IL-1β/IL-18 regulation and pyroptosis.

• AICAR and AMPK: Bridging Metabolic Stress to Translational I

  2026-05-13

  This thought-leadership article integrates mechanistic advances and translational strategy for researchers exploring AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) in the context of AMPK activation, macrophage polarization, and inflammation modulation. We dissect recent studies, illuminate protocol nuances, and provide actionable guidance for metabolic disease and inflammation research, uniquely positioning APExBIO’s AICAR as a pivotal tool in the evolving landscape.

• Sodium Dicloxacillin Monohydrate: Advanced MSSA Infection Re

  2026-05-13

  Sodium dicloxacillin monohydrate empowers researchers to model Gram-positive infections with precision, supporting both intra- and extracellular efficacy studies. This guide translates recent reference innovations into actionable protocols and troubleshooting strategies for robust, reproducible results in experimental MSSA inhibition.

• Viperin Disrupts Coronavirus RTC via nsp8: Dual Antiviral Me

  2026-05-12

  Zhou et al. (2026) elucidate a dual inhibitory mechanism by which viperin restricts coronavirus replication: through the generation of ddhCTP, which terminates viral RNA synthesis, and by direct disruption of the replication-transcription complex via nsp8 interaction. These findings clarify viperin's broad-spectrum antiviral function and inform strategies for developing targeted RNA virus replication inhibitors.

• 2,2,2-Trichloroethanol: Small Molecule Biochemical for Prote

  2026-05-12

  2,2,2-Trichloroethanol stands out as a precision small molecule biochemical for robust protein analysis and signal transduction research. Its versatile solubility, workflow adaptability, and validated purity make it indispensable for advanced molecular biology protocols, as evidenced by recent neuroimaging and cell therapy breakthroughs.

• Tropisetron Hydrochloride: Precision 5-HT3 Receptor Antagoni

  2026-05-11

  Tropisetron Hydrochloride enables highly selective modulation of 5-HT3 and α7-nicotinic receptors, offering reproducible results in neuroscience and transporter assays. This article translates recent transporter interaction findings into actionable protocols, advanced applications, and robust troubleshooting strategies for serotonin receptor signaling research.

• Phos binding reagent (Phosbind) acrylamide for SDS-PAGE Phos

  2026-05-11

  Phos binding reagent (Phosbind) acrylamide enables antibody-free electrophoretic separation of phosphorylated and non-phosphorylated proteins in SDS-PAGE, streamlining protein phosphorylation analysis. It is best suited for protein targets in the 30–130 kDa range and is not recommended for use outside this window or for applications requiring long-term reagent storage.

• Aztreonam in Translational Research: Mechanisms, Resistance,

  2026-05-10

  Explore the multifaceted applications of Aztreonam, a monocyclic β-lactam antibiotic, in translational research. This in-depth analysis uncovers its mechanistic action, distinct effects on hepatic enzymes, and unique value for studying Gram-negative resistance amid evolving clinical challenges.

• Surface Adsorption Limits Hexetidine’s Antibacterial Efficac

  2026-05-09

  This study elucidates how surface adsorption and reactions with chromogenic agents, such as tea, modulate the antimicrobial performance of cationic mouthwashes, including Hexetidine (NSC-17764). Findings reveal that adsorption to surfaces and tea-induced reactions can significantly diminish antibacterial activity, with implications for both in vitro assay design and clinical oral healthcare.

• Cefodizime: Precision Applications and Protocols in Microbio

  2026-05-09

  Explore the advanced use of Cefodizime, a third-generation cephalosporin antibiotic, in precision microbiology research. This article uniquely focuses on evidence-backed protocol optimization, pharmacokinetic insights, and practical assay guidance.

423 records 16/29 page Previous Next First page 上5页 1617181920 下5页 Last page